Simon Girmai Berger, Birgit Nomeland Witczak, Silje Reiseter, Thomas Schwartz, Helena Andersson, Siri Opsahl Hetlevik, Kristin Schjander Berntsen, Helga Sanner, Vibke Lilleby, Ragnar Gunnarsson, Øyvind Molberg, Ivar Sjaastad, Mathis Korseberg Stokke
We aimed to identify cardiac function in patients with established mixed connective tissue disease (MCTD). This was a cross-sectional case-control study of well-characterised MCTD patients who had previously been included in a nationwide cohort. Assessments comprised protocol transthoracic echocardiography, electrocardiogram and blood samples. In patients only, we evaluated the findings of high-resolution pulmonary computed tomography and disease activity. We assessed 77 MCTD patients (mean age 50.5 ± 12...
March 18, 2023: Rheumatology International
Varun Dhir, Chandra Bhushan Prasad, Sandeep Kumar, Kavya Kriti Kaul, Neha Dung, G S R S N K Naidu, Shefali K Sharma, Aman Sharma, Sanjay Jain
There is little data on long-term persistence/continuation of methotrexate among Indian Rheumatoid arthritis patients. We assembled a retrospective single-center cohort consisting of RA patients (fulfilling 1987 ACR criteria) started on methotrexate as part of three academic studies (including two RCTs) from 2011 to 2016. Oral methotrexate was started at 7.5 or 15 mg per week with a target dose of 25 mg per week. Between August and December 2020, all patients were contacted (telephonically) and data were obtained from clinic files to evaluate self-reported continuation/persistence of methotrexate and reasons for discontinuation...
March 18, 2023: Rheumatology International
Tatjana Zekić
Anti-synthetase syndrome (ASS) is an idiopathic inflammatory myopathy (IIM). In comparison to interstitial lung disease (ILD) in polymyositis and dermatomyositis (PM/DM), ILD in ASS is more frequent, has a more aggressive phenotype, a greater involvement of the lungs, and a more rapid onset of pulmonary symptoms. Continuous declines in predicted forced vital capacity (FVC) and dyspnea were the main features of patients who developed end-stage ILD. The severity of ASS at diagnosis dictates when and which immunosuppressant will be started...
March 16, 2023: Rheumatology International
Katarzyna Łosińska, Mariusz Korkosz, Are Hugo Pripp, Glenn Haugeberg
Randomized controlled trials showed high comparability of biosimilar rituximab (bs-RTX) GP2013 to biologic originator RTX (bo-RTX). Data on effectiveness of switching from bo-RTX to bs-RTX, starting therapy with bs-RTX, and bs-RTX drug survival in real-world setting are sparse. To explore long-term drug effectiveness and survival of bs-RTX GP2013 in rheumatoid arthritis (RA) patients both naïve to and mandatory switched from bo-RTX, and to clarify reasons for treatment cessation. Retrospective observational cohort study including RA outpatient clinic patients treated with bs-RTX between 2018 and 2021 in Norway...
March 16, 2023: Rheumatology International
Camilla Wibrand, Nini Kyvsgaard, Anne Estmann Christensen, Troels Herlin
Methotrexate (MTX) plays a key role when treating juvenile idiopathic arthritis (JIA), but MTX-intolerance is challenging. MTX-treatment might affect the liver, causing elevated levels of alanine aminotransferase (ALT), yet the role of ALT-levels in MTX-intolerance in JIA remains unclear. Our study aimed to investigate the association between ALT-levels during MTX-treatment and MTX-intolerance in JIA. Children (> 9 years old) diagnosed with JIA and treated with MTX (> 6 weeks) were eligible for enrollment...
March 15, 2023: Rheumatology International
Desislava Simeonova, Tsvetoslav Georgiev, Tanya Shivacheva
Takayasu's arteritis (TA) is a chronic granulomatous vasculitis that predominantly affects the aorta and its major branches. Despite advancements in the understanding of the pathogenic pathways of vascular inflammation, the etiology and predisposing factors of TA remain to be fully understood. In susceptible individuals, exposure to adjuvants may trigger, unlock or unmask an autoimmune disorder, presenting as non-specific constitutional symptoms or a fully developed autoimmune syndrome such as vasculitis. Here, we hypothesize that TA could be triggered by siliconosis, a subtype of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA)...
March 15, 2023: Rheumatology International
Tayyeba Khursheed, Muhammad Sharif, Muhammad Sufyan Khan, Ahmed Masood, Wajahat Aziz, Somaya Shah, Latika Gupta, Muhammad Arqam Miraj
Physician burnout is recognized as a global crisis and an epidemic. However, burnout in rheumatology is an understudied phenomenon. We explored the prevalence of physician burnout among rheumatologists from South Asia in the peri-pandemic period (2021-2022). Rheumatologists from Asian countries were invited to participate in an anonymized, validated, and pilot-tested e-survey via social media platforms from December 2021 to April 2022. Demographic information, social aspects (marital status, income, vacation time, daily exercise), substance abuse, EHR (electronic health record) use, and years in practice were obtained...
March 14, 2023: Rheumatology International
Aldona Wróbel, Joanna Szklarczyk, Ilona Barańska, Anna Majda, Jolanta Jaworek
Rheumatoid arthritis (RA) is a chronic systemic connective tissue disease of autoimmune basis. It is characterized by inflammation of joints and systemic complications. The etiopathogenesis is still unknown. Predisposing factors for the disease include genetic, immunological and environmental. Chronic disease and the stress experienced by patients disrupt the body's homeostatic state and weaken the human immune system. Reduced immunity and endocrine disruption may influence the development of autoimmune diseases and exacerbate their course...
March 13, 2023: Rheumatology International
Ping Li, Yuejia Zhou, Huanyu Liu, Weihua Yin, Jian Li, Minghua Luo
IgG4-related disease (IgG4-RD), a rare immune-mediated chronic fibro-inflammatory condition, has various initial symptoms, thus posing diagnostic and therapeutic challenges. Here, we report a case of IgG4-RD in a 35-year-old man with initial clinical symptoms of facial edema and recent onset of proteinuria. It took more than 1 year from the onset of clinical symptoms to diagnosis. Pathological examination of renal biopsy revealed significant renal interstitial lymphoid tissue hyperplasia simulating growth pattern of lymphoma...
March 13, 2023: Rheumatology International
Lisa S Traboco, Geraldine Zamora-Abrahan, Sheila Marie Reyes, Pavel V Ovseiko, Nimrat Kaur Sandhu, Latika Gupta
Gender parity at conferences can facilitate progress in academia towards the attainment of gender equality as emphasized in the United Nations' Sustainable Development Goals. The Philippines is a low to middle-income country in the Asia Pacific with relatively egalitarian gender norms experiencing significant growth in rheumatology. We examined the Philippines as a case study to analyze the impact of divergent gender norms on gender equity in rheumatology conference participation. We used publicly available data from PRA conference materials from 2009 to 2021...
March 13, 2023: Rheumatology International
Ezgi Deniz Batu, Aybüke Günalp, Sezgin Şahin, Semanur Özdel, Zehra Kızıldağ, Aysenur Pac Kısaarslan, İlknur Bağrul, Muserref Kasap Cuceoglu, Ayşe Tanatar, Hafize Emine Sonmez, Erdal Sag, Selcan Demir, Elif Çelikel, Sengul Cağlayan, Banu Çelikel Acar, Betül Sözeri, Nuray Aktay Ayaz, Yelda Bilginer, M Hakan Poyrazoğlu, Erbil Ünsal, Özgür Kasapçopur, Seza Özen
Pediatric mixed connective tissue disease (MCTD) is a subgroup of overlap syndromes. We aimed to compare the characteristics and outcomes in children with MCTD and other overlap syndromes. All MCTD patients met either Kasukawa or Alarcon-Segovia and Villareal criteria. The patients with other overlap syndromes had the features of ≥ 2 autoimmune rheumatic diseases but did not meet MCTD diagnostic criteria. Thirty MCTD (F/M = 28/2) and thirty (F/M = 29/1) overlap patients were included (disease onset < 18 years)...
March 12, 2023: Rheumatology International
Hutan Ashrafian
No abstract text is available yet for this article.
March 11, 2023: Rheumatology International
Natalie L Clark, Melissa Johnson, Amar Rangan, Lucksy Kottam, Katherine Swainston
Joint hypermobility affects approximately 30% of the United Kingdom (UK) population, characterised by the ability to move joints beyond the physiological limits. Associated conditions include Ehlers-Danlos syndrome and hypermobility spectrum disorders, affecting individuals across physical, psychological and social levels detrimentally impacting their health and wellbeing. The scoping review aims to describe the known biopsychosocial impact of joint hypermobility conditions in adults over the last decade. Additional objectives include to (1) identify the types of studies that address these factors, (2) to understand how the impact of the condition is measured and managed and (3) what healthcare professionals (HCPs) are involved...
March 10, 2023: Rheumatology International
Attila Feher, Edward J Miller, Dana C Peters, Hamid R Mojibian, Albert J Sinusas, Monique Hinchcliff, Lauren A Baldassarre
Impaired left-ventricular (LV) and right-ventricular (RV) cardiac magnetic resonance (CMR) strain has been documented in systemic sclerosis (SSc). However, it is unknown whether the CMR strain is predictive of adverse outcomes in SSc. Therefore, we set out to investigate the prognostic value of CMR strain in SSc. Patients with SSc who underwent CMR for clinical indications between 11/2010 and 07/2020 were retrospectively studied. LV and RV strain was evaluated by feature tracking. The association between strain, late gadolinium enhancement (LGE), and survival was evaluated with time to event and Cox-regression analyses...
March 10, 2023: Rheumatology International
Serkan Coşkun, Zahide Ekici Tekin, Vildan Güngörer, Elif Çelikel, Tuba Kurt, Merve Cansu Polat, Pakize Nilüfer Tekgöz, Müge Sezer, Cüneyt Karagöl, Melike Mehveş Kaplan, Nimet Öner, Hazım Alper Gürsu, Ahmet Vedat Kavurt, Zeliha Güzelküçük, Namık Yaşar Özbek, Banu Çelikel Acar
To evaluate the general characteristics of pediatric Behçet's disease (BD) patients with thrombus and to present the clinical features, treatment responses and prognosis of patients with intracardiac thrombus. The clinical characteristics and outcomes of 15 patients with thrombus among 85 pediatric BD patients followed in the Department of Pediatric Rheumatology were evaluated retrospectively. Of the 15 BD patients with thrombus, 12 (80%) were male, 3 (20%) were female. The mean age at diagnosis was 12...
March 9, 2023: Rheumatology International
Mehmet Engin Tezcan, Sevtap Acer Kasman, Nesrin Şen, Sibel Osken, Sibel Yılmaz-Oner
There are limited follow-up parameters for familial Mediterranean fever (FMF) related to disease severity and amyloidosis. Some hematological markers are emerging to assess inflammation. In this study, we hypothesized that some hematological parameters could be used to determine disease severity and amyloidosis in FMF. We included 274 adult FMF patients, and evaluated the relationship between neutrophil lymphocyte ratio (NLR), monocyte-lymphocyte ratio (MLR) and platelet-lymphocyte ratio (PLR), platelet counts and leukocyte counts, mean erythrocyte haemoglobin concentration (MCHC) and mean erythrocyte haemoglobin (MCH) with disease severity and amyloidosis...
March 6, 2023: Rheumatology International
Anna Felis-Giemza, Kornelia Chmurzyńska, Beata Kołodziejczyk, Agnieszka Gazda
The study aimed to assess how many adult patients with juvenile idiopathic arthritis (JIA) treated with biologics fulfill classification criteria for adult rheumatic diseases and to evaluate the course of JIA in adulthood. 138 patients with JIA over 18 years old treated with biologics were included in a cross-sectional observative study. Among 138 adult patients with JIA treated with biologics, 81 patients remained with JIA diagnosis. 57 patients were rediagnosed. 31 patients met the criteria for spondyloarthropathy, among them 18 patients for ankylosing spondylitis, 10 patients for psoriatic arthritis, and 3 patients for non-radiographic axial spondyloarthritis...
March 1, 2023: Rheumatology International
Burhan Fatih Kocyigit, Zhaxybek Sagtaganov, Marlen Yessirkepov
Yoga, a long-standing Indian tradition, has gained popularity globally, inspiring many different disciplines to employ it as a complementary treatment for various diseases. Yoga is primarily composed of numerous physical poses and positions that are coupled with breathing techniques, profound relaxation, and meditation. There are many types of yoga with varying levels of difficulty. Yoga, consisting of various poses and postures with distinct postural mechanics, is frequently highlighted as an exercise that improves both physical and mental health...
March 1, 2023: Rheumatology International
Petros P Sfikakis, Dimitrios Vassilopoulos, Gkikas Katsifis, Georgios Vosvotekas, Theodoros Dimitroulas, Prodromos Sidiropoulos, Periklis Vounotrypidis, Dimitrios P Bogdanos, Athanasios Ι Georgountzos, Andreas G Bounas, Panagiotis Georgiou, Souzana Gazi, Evangelia Kataxaki, Stamatis-Nick Liossis, Evangelos Theodorou, Charalampos Papagoras, Evangelos Theotikos, Panayiotis Vlachoyiannopoulos, Paraskevi V Voulgari, Angeliki Kekki, Nikolaos Antonakopoulos, Dimitrios T Boumpas
To evaluate the effect of the phosphodiesterase 4 inhibitor apremilast in biologic-naïve patients with early peripheral PsA in terms of disease activity, clinical manifestations, patient-perceived outcomes, as well as apremilast's safety profile in routine care settings of Greece. Non-interventional, multicenter, 52-week prospective cohort study, enrolling biologic-naïve patients with early active peripheral PsA who started apremilast after intolerance or inadequate response (within the first 12 months of treatment) to an initial conventional synthetic (cs)DMARD treatment...
March 1, 2023: Rheumatology International
L Mekenyan, R Karalilova, P Todorov, N Tepeliev, A Batalov
Polymyalgia rheumatica (PMR) is an inflammatory joint disease in patients over 50 years of age with pain and prolonged morning stiffness in the shoulder and hip girdles and neck. The lack of specific clinical findings, laboratory signs, biomarker and established imaging methods makes it difficult to diagnose patients with this disease. The aim of the systematic review is to present the literature data on the use of imaging methods for early diagnosis, assessment of disease activity and therapeutic response in PMR...
February 28, 2023: Rheumatology International
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.